Results From A Phase III Trial Proton Therapy In Head And Neck Cancer

A groundbreaking multi-institution Phase III trial led by The University of Texas MD Anderson Cancer Center reveals that intensity modulated proton therapy (IMPT) provides significant benefits for patients with oropharyngeal cancer. Compared to traditional intensity modulated radiation therapy (IMRT), IMPT showed similar progression-free survival rates but significantly reduced malnutrition and feeding-tube dependence. With a median follow-up of […]